Wang Xiaolin bought RVMD
March 1, 2026 · Form 4 insider transaction
Wang Xiaolin bought 15,100 shares of Revolution Medicines, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,100
Price
$0.00
Total value
N/A
InsiderWang Xiaolin
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after118,073
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 54,464 restricted stock units.; Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025.